| Literature DB >> 27885351 |
Santosh Kumar Sinha1, Vikas Mishra1, Nasar Afdaali1, Mukesh Jitendra Jha1, Ashutosh Kumar1, Mohammad Asif1, Ramesh Thakur1, Chandra Mohan Varma1.
Abstract
Background and Aim. The aim of study was to evaluate safety, feasibility, and procedural variables of transradial approach compared with transfemoral approach in a standard population of patients undergoing coronary catheterization as one of the major criticisms of the transradial approach is that it takes longer overall procedure and fluoroscopy time, thereby causing more radiation exposure. Method. Between January 2015 and December 2015, a total of 1,997 patients in LPS Institute of Cardiology, GSVM Medical College, Kanpur, UP, India, undergoing coronary catheterization were randomly assigned to the transradial or transfemoral approach. Result. Successful catheterization was achieved in 1045 of 1076 patients (97.1%) in the transradial group and in 918 of 921 patients (99.7%) in the transfemoral group (p = 0.001). Comparing the transradial and transfemoral approaches, fluoroscopy time (2.46 ± 1.22 versus 2.83 ± 1.31 min; p = 0.32), procedure time (8.89 ± 2.72 versus 9.33 ± 2.82 min; p = 0.56), contrast volume (67.52 ± 22.54 versus 71.63 ± 25.41 mL; p = 0.32), radiation dose as dose area product (24.2 ± 4.21 versus 22.3 ± 3.46 Gycm2; p = 0.43), and postprocedural rise of serum creatinine (6 ± 4.5% versus 8 ± 2.6%; p = 0.41) were not significantly different while vascular access site complications were significantly lower in transradial group than transfemoral group (3.9% versus 7.6%; p = 0.04). Conclusion. The present study shows that transradial access for coronary angiography is safe among patients compared to transfemoral access with lower rate of local vascular complications.Entities:
Year: 2016 PMID: 27885351 PMCID: PMC5112320 DOI: 10.1155/2016/4013843
Source DB: PubMed Journal: Cardiol Res Pract ISSN: 2090-0597 Impact factor: 1.866
Figure 1(a) TR band; various internal diameters of radial artery (b, c, d, and e); RAO with collaterals (f).
Figure 2Few of the complications of transradial catheterization: vasospasm, focal (a); vasospasm, diffuse (b); perforation (c); dissection (d).
Figure 3Reasons of radial crossover from transfemoral route: tortuous and calcified aorta.
Baseline characteristics of patients (n = 1997).
| Characteristic | Transradial CAG ( | Transfemoral CAG ( |
|
|---|---|---|---|
| Age (years) | 51 ± 16.4 | 49 ± 14.9 | 0.16 |
| Male | 856 (79.6%) | 700 (71.7) | 0.2 |
| Female | 220 (20.4%) | 221 (28.3) | 0.23 |
| Height (cm) | 166.5 ± 10.8 | 154 ± 8.4 | 0.4 |
| Weight (kg) | 63.6 ± 11.2 | 59.2 ± 9.6 | 0.18 |
| BMI (kg/m2) | 24.9 ± 2.8 | 23.8 ± 3.6 | 0.4 |
| BSA (m2) | 1.66 ± 0.22 | 1.62 ± 0.19 | 0.24 |
| Serum creatinine (mg/dL) | 1.2 ± 0.3 | 1.3 ± 0.4 | 0.4 |
|
| |||
| Hypertension | 421 (39.1) | 313 (34 ) | 0.32 |
| Diabetes mellitus | 358 (33.2) | 268 (29 ) | 0.29 |
| Smokers | 323 (30) | 323 (35 ) | 0.31 |
| Family history of CAD | 76 (7.1) | 37 (4 ) | 0.43 |
| Dyslipidemia | 441 (41) | 335 (36.4 ) | 0.22 |
|
| |||
| Acute coronary syndrome | 676 (62.8) | 543 (58.9) | 0.12 |
| Chronic stable angina | 355 (33) | 240 (26.1) | 0.32 |
| Cardiomyopathy | 07 (0.6) | 38 (4.1) | 0.05 |
| Chest pain for evaluation | 27 (2.5) | 46 (4.9) | 0.53 |
| Previous CABG | 07 (0.6) | 31 (3.3) | 0.04 |
| Valvular heart disease | 4 (0.3) | 23 (2.4) | 0.02 |
| LVEF (%) | |||
| (a) >45% | 818 (76) | 646 (70.2) | 0.32 |
| (b) 35–45% | 120 (11.2) | 154 (16.7) | 0.21 |
| (c) <35% | 138 (12.8) | 120 (13.1 ) | 0.4 |
|
| |||
| Aspirin | 1002 (93.2) | 708 (76.9) | 0.5 |
| Clopidogrel | 55 (50.6) | 636 (69.1) | 0.3 |
| Prasugrel | 132 (12.3) | 169 (18.4) | 0.11 |
| Ticagrelor | 58 (5.8) | 29 (3.2) | 0.33 |
| Statin | 981 (91.2) | 722 (78.4) | 0.7 |
| Beta-blocker | 785 (72.9) | 620 (67.4) | 0.53 |
| ACEI/ARB | 974 (90.5) | 754 (81.9) | 0.19 |
| CCB | 230 (21.4) | 268 (29.2) | 0.5 |
| Aldosterone antagonist | 132 (12.3) | 84 (9.2) | 0.31 |
|
| 743 (69.1) | 723 (78.6) | 0.42 |
| (a) SVD | 350 (47.2) | 420 (58.2) | 0.18 |
| (b) DVD | 212 (28.6) | 161 (22.2) | 0.56 |
| (c) TVD | 181 (20.4) | 104 (14.3) | 0.67 |
| (d) Left main (isolated ± other vessel) | 41 (3.8) | 38 (5.3 ) | 0.3 |
| CAD (intermediate 50–70%) | 177 (16.4) | 103 (11.2) | 0.29 |
| Non-obs. CAD (recanalised) | 97 (8.9) | 38 (4.2) | 0.44 |
| Normal coronaries | 59 (5.4) | 55 (6) | 0.31 |
Data presented as mean ± standard deviation or number (percentage). BMI = body mass index; BSA = body surface area; CAD = coronary artery disease; DM = diabetes mellitus; LVEF = left ventricular ejection fraction; ACEI = angiotensin-converting enzyme inhibitor; ARB = angiotensin-receptor blocker; CCB = calcium-channel blocker; SVD = single-vessel disease; DVD = double-vessel disease; TVD = triple-vessel; CABG = coronary artery bypass graft.
Procedural and postprocedural outcome of patients (n = 1, 997).
| Variables | Transradial CAG ( | Transfemoral CAG ( |
|
|---|---|---|---|
| Catheters used | |||
| (a) Single catheter | 1034 (96.1) | 10 (1.1) | 0.24 |
| (b) Catheter exchanged | 42 (4.9.) | 911 (98.9) | |
| Crossover rate | |||
| (a) Radial to femoral | 31 (2.9) | — | 0.001 |
| (b) Femoral to radial | — | 3 (0.3) | |
| UFH | 1076 (100%) | 921 (100) | 0.22 |
| Duration of radial artery compression (Hr.) | 2.1 ± 0.2 | — | 0.12 |
| Fluoroscopy time (min) | 2.46 ± 1.22 | 2.83 ± 1.31 | 0.32 |
| Radiation dose (Gy × cm2) | 24.2 ± 4.21 | 22.3 ± 3.46 | 0.43 |
| Procedure duration | 8.89 ± 2.72 | 9.33 ± 2.82 | 0.56 |
| Contrast volume (mL) | 67.52 ± 22.54 | 71.63 ± 25.41 | 0.32 |
| Serum creatinine (mg/dL), post-CAG | 1.3 ± 0.2 (6 ± 4.5) | 1.4 ± 0.15 (8 ± 2.6) | 0.41 |
| RAO | 56 (5.2) | — | — |
| Vasospasm | 28 (2.6) | — | — |
|
| 43 (3.9) | 70 (7.6) | 0.04 |
| Local site pain | 21 (1.9) | 38 (4.1) | 0.04 |
| Haematoma | 9 (0.83) | 13 (1.4) | 0.001 |
| Local site paraesthesia | 13 (1.2) | 19 (2.1) | 0.03 |
Including one for crossover; UFH: unfractionated heparin; CAG: Coronary Arteriography; RAO: radial artery occlusion.